Data Disparities Supplement to Johns Hopkins Institute for Clinical and Translational Research
约翰·霍普金斯临床和转化研究所的数据差异补充
基本信息
- 批准号:10158718
- 负责人:
- 金额:$ 49.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-05 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAccountingAddressAdministrative SupplementAdult Respiratory Distress SyndromeAfrican AmericanAttentionBehaviorCOVID-19COVID-19 pandemicCaringCessation of lifeChinaChronicClinical ResearchColorCommunitiesComputerized Medical RecordContractsCoronavirusCoughingCountryDataDiabetes MellitusDisadvantagedDiseaseDistrict of ColumbiaEventFaceFeverGeographic LocationsGeographyHealthHealth InsuranceHealth ServicesHealth systemHispanic AmericansHypertensionInfectionInstitutesLower Respiratory Tract InfectionLungMarylandNative AmericansNeighborhoodsPatientsPersonsPneumoniaPopulationRaceRegistriesResearchResearch PersonnelResourcesRiskSecureSocial DistanceSocioeconomic StatusSore ThroatStructureSymptomsSystemTestingTimeTranslational ResearchUnited StatesViruscare outcomescohortcoronavirus diseasedata accessdata modelingdata resourceethnic minority populationhealth care deliveryhealth disparitymedical specialtiesminority communitiespandemic diseasepopulation basedprecision medicineracial and ethnicracial minorityracismrespiratorysocial health determinantssocioeconomic disadvantage
项目摘要
The SARS-CoV-2 coronavirus, which causes a respiratory illness known as Coronavirus Disease 2019
(COVID-19), has caused a global pandemic of unprecedented proportion. As of April 28, 2020, there were over
3 million confirmed COVID-19 cases worldwide, including over 1 million cases within the United States. In
addition, there has been over 213,000 COVID-19 related deaths globally, including 57,000 deaths in the United
States. The COVID-19 pandemic is disproportionately impacting racial/ethnic minority communities, as well as
those who face socioeconomic disadvantage. Reasons for this disproportionate impact among racial/ethnic
minorities include a greater burden of the chronic health conditions that place persons at risk of severe disease
and death from COVID-19, poorer access to primary and specialty care, an increased risk of contracting
COVID-19 due to barriers to practicing social distancing behaviors, and shortages of testing resources in
disadvantaged communities. This pandemic has presented unprecedented needs for timely access to health-
related data. The State of Maryland and surrounding regions including the District of Columbia are fortunate to
have a well-functioning health information exchange, CRISP. During the COVID-19 pandemic, CRISP data
have the potential to serve an essential function in tracking and understanding the care and outcomes of
COVID-19 infections. This resource would be unique among COVID registries in that it includes all health
events and findings among the entire population of a geographic area, regardless where a health service was
delivered. As such, it is ideally suited to address questions of health disparities. The Specific Aims of this
administrative supplement are to (1) develop the CRISP data resource as a unique, population-based COVID-
19 registry on the highly secure Johns Hopkins Precision Medicine Analytics Platform, and (2) evaluate
COVID-19 care and outcomes by race, neighborhood and socioeconomic status such that targeted strategies
can be deployed to reduce emerging disparities.
SARS-COV-2冠状病毒导致呼吸道疾病,称为冠状病毒病2019
(Covid-19)引起了前所未有的比例的全球大流行。截至2020年4月28日,已经结束了
300万确认了全世界的Covid-19案件,其中包括美国境内超过100万个案件。在
此外,全球已有超过213,000 covid相关的死亡,其中包括57,000人死亡
国家。 19009年大流行对种族/族裔少数民族社区以及
那些面对社会经济劣势的人。种族/族裔之间这种不成比例影响的原因
少数民族包括慢性健康状况的负担,使人们面临严重疾病的风险
以及Covid-19的死亡,获得初级和专业护理的不良访问权限,收缩风险增加
COVID-19由于练习社会疏远行为的障碍以及测试资源短缺
处境不利的社区。这个大流行已经提出了及时获得健康的前所未有的需求
相关数据。马里兰州及其周边地区在内,包括哥伦比亚特区很幸运
具有功能齐全的健康信息交换,清脆。在COVID-19大流行期间,清晰的数据
有潜力在跟踪和了解的护理和结果方面发挥重要作用
Covid-19感染。该资源在Covid注册表中是独一无二的,因为它包括所有健康
地理区域的整个人口中的事件和发现,无论医疗服务在哪里
发表。因此,它非常适合解决健康差异问题。这个特定的目的
行政补充是(1)将CRIRP数据资源作为一种独特的,基于人群的Covid-
19在高度安全的约翰·霍普金斯精密医学分析平台上的注册表,以及(2)评估
Covid-19-19划分的护理和成果按种族,邻里和社会经济地位,以便针对性的策略
可以部署以减少新兴差异。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Ernest Ford其他文献
Daniel Ernest Ford的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Ernest Ford', 18)}}的其他基金
The Johns Hopkins Clinical Research Scholars in Women's Health (BIRCWH)
约翰霍普金斯大学女性健康临床研究学者 (BIRCWH)
- 批准号:
10683615 - 财政年份:2022
- 资助金额:
$ 49.27万 - 项目类别:
QAQC Johns Hopkins Institute for Clinical and Translational Research
QAQC 约翰霍普金斯临床与转化研究所
- 批准号:
10158890 - 财政年份:2020
- 资助金额:
$ 49.27万 - 项目类别:
Johns Hopkins Institute for Clinical and Translational Research
约翰·霍普金斯临床与转化研究所
- 批准号:
10398028 - 财政年份:2019
- 资助金额:
$ 49.27万 - 项目类别:
Johns Hopkins Institute for Clinical and Translational Research
约翰·霍普金斯临床与转化研究所
- 批准号:
10615648 - 财政年份:2019
- 资助金额:
$ 49.27万 - 项目类别:
Johns Hopkins Institute for Clinical and Translational Research
约翰·霍普金斯临床与转化研究所
- 批准号:
9892396 - 财政年份:2019
- 资助金额:
$ 49.27万 - 项目类别:
Achieving Ethically Appropriate and Effective Local Context Review by Single IRBs
由单一 IRB 实现道德上适当且有效的当地情况审查
- 批准号:
10594273 - 财政年份:2019
- 资助金额:
$ 49.27万 - 项目类别:
The Johns Hopkins Clinical Research Scholars in Women's Health (BIRCWH)
约翰霍普金斯大学女性健康临床研究学者 (BIRCWH)
- 批准号:
10457011 - 财政年份:2015
- 资助金额:
$ 49.27万 - 项目类别:
The Johns Hopkins Clinical Research Scholars in Women's Health (BIRCWH)
约翰霍普金斯大学女性健康临床研究学者 (BIRCWH)
- 批准号:
9509866 - 财政年份:2015
- 资助金额:
$ 49.27万 - 项目类别:
The Johns Hopkins Clinical Research Scholars in Women's Health (BIRCWH)
约翰霍普金斯大学女性健康临床研究学者 (BIRCWH)
- 批准号:
10227668 - 财政年份:2015
- 资助金额:
$ 49.27万 - 项目类别:
The Johns Hopkins Clinical Research Scholars in Women's Health (BIRCWH)
约翰霍普金斯大学女性健康临床研究学者 (BIRCWH)
- 批准号:
10646314 - 财政年份:2015
- 资助金额:
$ 49.27万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
- 批准号:
10661931 - 财政年份:2023
- 资助金额:
$ 49.27万 - 项目类别:
NeuroMAP Phase II - Recruitment and Assessment Core
NeuroMAP 第二阶段 - 招募和评估核心
- 批准号:
10711136 - 财政年份:2023
- 资助金额:
$ 49.27万 - 项目类别:
Using wastewater surveillance data to study SARS-CoV-2 dynamics and predict COVID-19 outcomes
利用废水监测数据研究 SARS-CoV-2 动态并预测 COVID-19 结果
- 批准号:
10645617 - 财政年份:2023
- 资助金额:
$ 49.27万 - 项目类别:
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
- 批准号:
10727092 - 财政年份:2023
- 资助金额:
$ 49.27万 - 项目类别:
Examining linkages between disrupted care and chronic disease outcomes during the COVID-19 pandemic: a VAMC level spatio-temporal analysis
检查 COVID-19 大流行期间中断的护理与慢性病结果之间的联系:VAMC 级别时空分析
- 批准号:
10641136 - 财政年份:2023
- 资助金额:
$ 49.27万 - 项目类别: